DAWN Next Earnings Date Notes

— Day One Biopharmaceuticals (NASDAQ: DAWN) is a clinical-stage biopharmaceutical company focused on developing targeted therapies for patients with life-threatening diseases, with an emphasis on pediatric and adolescent cancers. The company’s leading asset is tovorafenib, an oral, brain-penetrant, type II RAF kinase inhibitor, currently in pivotal trials for pediatric low-grade glioma (pLGG) and other RAF-altered tumors. When listening to the next DAWN earnings call, investors should focus on milestones and updates related to tovorafenib’s clinical progress, including enrollment rates, data readouts, regulatory interactions & timelines for possible NDA/BLA submissions. Additionally, cash runway & burn rate are critical metrics, as Day One operates pre-commercial & relies heavily on available cash to advance its pipeline. Other relevant business metrics include partnership or licensing updates, progress with additional pipeline candidates, and any commentary on market size or commercialization strategy. Monitoring these factors will provide the clearest insight into DAWN’s long-term trajectory & its potential to bring first-in-class therapies to underserved patient populations. The next projected earnings date for DAWN is 5/19/2026 after close (stay tuned for a confirmed earnings date once announced).

DAWN Next Earnings Date FAQ

On this page we presented the DAWN Next Earnings Date information for Day One Biopharmaceutical along with recent past earnings dates. For Q4 of 2025, DAWN reported earnings of -0.210/share, with the earnings report taking place on 2/24/2026. For Q3 of 2025, DAWN reported earnings of -0.190/share, with the earnings report taking place on 11/4/2025. For Q2 of 2025, DAWN reported earnings of -0.290/share, with the earnings report taking place on 8/5/2025. For Q1 of 2025, DAWN reported earnings of -0.350/share, with the earnings report taking place on 5/6/2025. For Q4 of 2024, DAWN reported earnings of -0.690/share, with the earnings report taking place on 2/25/2025. Based on these past earnings dates, the projected next earnings date for DAWN is 5/19/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Day One Biopharmaceutical. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Day One Biopharmaceutical shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Day One Biopharmaceutical next earnings dates as well as any other stock out there in our coverage universe, to see when the next DAWN earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up DAWN's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the DAWN next earnings date.